TA
REGN icon

Teachers Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Teachers Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$60.2M Buy
146,555
+3,195
+2% +$1.32M 0.07% 279
2018
Q4 		$53.5M Sell
143,360
-20,445
-12% -$7.48M 0.08% 268
2018
Q3 		$66.2M Buy
163,805
+9,307
+6% +$3.54M 0.08% 278
2018
Q2 		$53.3M Sell
154,498
-1,013
-0.7% -$317K 0.07% 338
2018
Q1 		$53.6M Buy
155,511
+412
+0.3% +$143K 0.07% 331
2017
Q4 		$58.3M Sell
155,099
-78,281
-34% -$31.7M 0.07% 313
2017
Q3 		$104M Buy
233,380
+12,430
+6% +$5.91M 0.14% 162
2017
Q2 		$109M Buy
220,950
+122,824
+125% +$53.7M 0.15% 154
2017
Q1 		$38M Buy
98,126
+4,136
+4% +$1.53M 0.06% 403
2016
Q4 		$34.5M Buy
93,990
+5,295
+6% +$2.01M 0.05% 402
2016
Q3 		$35.7M Buy
88,695
+5,118
+6% +$2.05M 0.06% 383
2016
Q2 		$29.2M Buy
83,577
+1,494
+2% +$575K 0.05% 433
2016
Q1 		$29.6M Sell
82,083
-176
-0.2% -$72.5K 0.05% 421
2015
Q4 		$44.7M Sell
82,259
-15,289
-16% -$8.28M 0.08% 300
2015
Q3 		$45.4M Buy
97,548
+21,886
+29% +$11.8M 0.09% 282
2015
Q2 		$38.6M Sell
75,662
-17,833
-19% -$8.7M 0.07% 358
2015
Q1 		$42.2M Buy
93,495
+12,091
+15% +$5.12M 0.08% 325
2014
Q4 		$33.4M Buy
81,404
+19,636
+32% +$7.72M 0.06% 385
2014
Q3 		$22.3M Buy
61,768
+280
+0.5% +$93.8K 0.04% 492
2014
Q2 		$17.4M Buy
61,488
+1,134
+2% +$336K 0.04% 628
2014
Q1 		$18.1M Sell
60,354
-974
-2% -$300K 0.04% 595
2013
Q4 		$16.9M Buy
61,328
+3,801
+7% +$1.09M 0.04% 595
2013
Q3 		$18M Sell
57,527
-37,511
-39% -$9.87M 0.04% 540
2013
Q2 		$21.4M Buy
+95,038
New +$22.1M 0.06% 430

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Teachers Advisors's REGN Position: Q1 2019 in Review

Teachers Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 2.2% in Q1 2019, buying an estimated $1.32M and bringing the position to 146,555 shares worth $60.2M. The position accounts for 0.07% of the portfolio, ranked #279.

Teachers Advisors first reported a position in REGN in Q2 2013 and has held it in 24 quarters since. The position peaked at $109M in Q2 2017. 719 funds tracked by Wall St. Rank hold REGN as of Q1 2019.

  • Teachers Advisors held 146,555 shares of Regeneron Pharmaceuticals worth $60.2M as of Q1 2019.
  • Teachers Advisors bought 3,195 Regeneron Pharmaceuticals shares in Q1 2019, an estimated $1.32M.
  • Regeneron Pharmaceuticals made up 0.07% of Teachers Advisors's portfolio in Q1 2019, its #279 holding.
  • Teachers Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Regeneron Pharmaceuticals position peaked at $109M in Q2 2017.
  • 719 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.